{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:38Z","timestamp":1707524138074},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,7]]},"DOI":"10.7759\/cureus.9599","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T08:01:19Z","timestamp":1596787279000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Hyperaldosteronism in End-Stage Renal Disease: Diagnostic Challenges and Treatment Considerations"],"prefix":"10.7759","author":[{"given":"Raj","family":"Chand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srijan","family":"Tandukar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadiyah","family":"Asmil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Chico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000274","article-title":"Diagnosis and management of primary aldosteronism","volume":"61","author":"Vilela LAP","year":"2017","unstructured":"Vilela LAP, Almeida MQ. Diagnosis and management of primary aldosteronism. Arch Endocrinol Metab. 2017, 61:305-312. 10.1590\/2359-3997000000274","journal-title":"Arch Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0115426505020002192","article-title":"Electrolytes and fluid management in hemodialysis and peritoneal dialysis","volume":"20","author":"Nanovic L","year":"2005","unstructured":"Nanovic L. Electrolytes and fluid management in hemodialysis and peritoneal dialysis. Nutr Clin Pract. 2005, 20:192-201. 10.1177\/0115426505020002192","journal-title":"Nutr Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young WF","year":"2007","unstructured":"Young WF. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007, 356:601-610. 10.1056\/NEJMcp065470","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d)","volume":"138","author":"Grumbach MM","year":"2003","unstructured":"Grumbach MM, Biller BMK, Braunstein GD, et al.. Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d). Ann Intern Med. 2003, 138:424-429. 10.7326\/0003-4819-138-5-200303040-00013","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio S","year":"2006","unstructured":"Bovio S, Cataldi A, Reimondo G, et al.. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006, 29:298-302. 10.1007\/BF03344099","journal-title":"J Endocrinol Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.12.006","article-title":"Adrenal incidentaloma","volume":"26","author":"Arnaldi G","year":"2012","unstructured":"Arnaldi G, Boscaro M. Adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab. 2012, 26:405-419. 10.1016\/j.beem.2011.12.006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005574","article-title":"Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study","volume":"6","author":"Maiolino G","year":"2017","unstructured":"Maiolino G, Rossitto G, Bisogni V, Cesari M, Seccia TM, Plebani M, Rossi GP; the PAPY Study Investigators. Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study. J Am Heart Assoc. 2017, 6:e005574. 10.1161\/JAHA.117.005574","journal-title":"J Am Heart Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl702","article-title":"Primary hyperaldosteronism in a patient with end-stage renal disease","volume":"22","author":"Kazory A","year":"2007","unstructured":"Kazory A, Weiner ID. Primary hyperaldosteronism in a patient with end-stage renal disease. Nephrol Dial Transplant. 2007, 22:917-919. 10.1093\/ndt\/gfl702","journal-title":"Nephrol Dial Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez P","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005, 45:1243-1248. 10.1016\/j.jacc.2005.01.015","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein J","year":"2005","unstructured":"Ribstein J, Du Cailar G, Fesler P, Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol. 2005, 16:1320-1325. 10.1681\/ASN.2004100878","journal-title":"J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/35917-primary-hyperaldosteronism-in-end-stage-renal-disease-diagnostic-challenges-and-treatment-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:20:25Z","timestamp":1707506425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/35917-primary-hyperaldosteronism-in-end-stage-renal-disease-diagnostic-challenges-and-treatment-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.9599","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,7]]}}}